Source:http://linkedlifedata.com/resource/pubmed/id/12700679
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-5-27
|
pubmed:abstractText |
The neuropeptide galanin coexists with norepinephrine and serotonin in neural systems mediating emotion. Previous findings suggested that galanin modulates anxiety-related behaviors in rodents. Three galanin receptor subtypes have been cloned; however, understanding their functions has been limited by the lack of galanin receptor subtype-selective ligands. To study the role of the galanin GAL-R1 receptor subtype in mediating anxiety-related behavior, we generated mice with a null mutation in the Galr1 gene. GAL-R1 -/- are viable and show no abnormalities in health, neurological reflexes, motoric functions, or sensory abilities. On a battery of tests for anxiety-like behavior, GAL-R1 -/- showed increased anxiety-like behavior on the elevated plus-maze test. Anxiety-related behaviors on the light/dark exploration, emergence, and open field tests were normal in GAL-R1 -/-. This test-specific anxiety-like phenotype was confirmed in a second, independent cohort of GAL-R1 null mutant mice and +/+ controls. Principal components factor analysis of behavioral scores from 279 mice suggested that anxiety-like behavior on the elevated plus-maze was qualitatively distinct from behavior on other tests in the battery. In addition, exposure to the elevated plus-maze produced a significantly greater neuroendocrine response than exposure to the light/dark exploration test, as analyzed in normal C57BL/6J mice. These behavioral findings in the first galanin receptor null mutant mouse are consistent with the hypothesis that galanin exerts anxiolytic actions via the GAL-R1 receptor under conditions of relatively high stress.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0893-133X
|
pubmed:author |
pubmed-author:CrawleyJacqueline NJN,
pubmed-author:HolmesAndrewA,
pubmed-author:IismaaTiina PTP,
pubmed-author:InnerfieldCaitlin ECE,
pubmed-author:JacobyArie SAS,
pubmed-author:KinneyJefferson WJW,
pubmed-author:LiQianQ,
pubmed-author:MaLiL,
pubmed-author:SaavedraMaria CMC,
pubmed-author:ShineJohnJ,
pubmed-author:VishwanathJananiJ,
pubmed-author:WrennCraige CCC,
pubmed-author:YangRebecca JRJ
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1031-44
|
pubmed:dateRevised |
2011-5-18
|
pubmed:meshHeading |
pubmed-meshheading:12700679-Animals,
pubmed-meshheading:12700679-Anxiety,
pubmed-meshheading:12700679-Darkness,
pubmed-meshheading:12700679-Exploratory Behavior,
pubmed-meshheading:12700679-Galanin,
pubmed-meshheading:12700679-Lighting,
pubmed-meshheading:12700679-Male,
pubmed-meshheading:12700679-Maze Learning,
pubmed-meshheading:12700679-Mice,
pubmed-meshheading:12700679-Mice, Inbred C57BL,
pubmed-meshheading:12700679-Mice, Knockout,
pubmed-meshheading:12700679-Motor Activity,
pubmed-meshheading:12700679-Receptors, Galanin,
pubmed-meshheading:12700679-Receptors, Neuropeptide
|
pubmed:year |
2003
|
pubmed:articleTitle |
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze.
|
pubmed:affiliation |
Section on Behavioral Genomics, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA. aholmes@intra.nimh.nih.gov
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|